1.Clinical Recognition and Management of Patients Exposed to Biological Warfare Agents : Anthrax, Smallpox, Plague, and Botulism.
Journal of the Korean Medical Association 2002;45(5):575-588
The recent cases of anthrax due to bioterrorism in the United States have reminded us that our society is also vulnerable to biological attacks. Illnesses due to bioterrorism are not naturally occurring diseases, and therefore may show presentations not familiar to many doctors. The last case of smallpox was reported in 1960, and doctors aged less than 60 years have no experience of smallpox. Anthrax is a rare zoonosis, and no case of inhalation anthrax has been reported in Korea. American doctors might be on high alert to bioterrorism after September 11, 2001. However, it took more than 2 weeks from the symptom onset of the index case to the recognition that anthrax outbreak had occurred due to bioterrorism. This delay shows how difficult it is to recognize bioterrorism. This article describes clinical recognition and management of patients exposed to biological warfare agents, especially agents causing anthrax, smallpox, plague, and botulism.
Anthrax
;
Biological Warfare Agents*
;
Biological Warfare*
;
Bioterrorism
;
Botulism*
;
Humans
;
Inhalation
;
Korea
;
Plague*
;
Smallpox
;
United States
2.Fever of Undeterminde Origin : Common Diseases.
Journal of the Korean Medical Association 1998;41(1):56-60
No abstract available.
Fever*
3.Bacillary Dysentery.
Journal of the Korean Medical Association 1999;42(7):637-640
No abstract available.
Dysentery, Bacillary*
4.Infections in organ transplant recipients.
Korean Journal of Medicine 2000;58(1):122-122
No abstract available.
Transplants*
5.A seroepidemiological study of Tsutsugamushi disease in ryral population in Korea.
Korean Journal of Infectious Diseases 1991;23(1):13-17
No abstract available.
Korea*
;
Scrub Typhus*
;
Seroepidemiologic Studies*
6.Treatment Strategy for Staphylococcus aureus Bacteremia.
Han Kim SUNG ; Don Oh MYOUNG ; Won Choe KANG
Korean Journal of Infectious Diseases 2002;34(6):380-390
No abstract available.
Bacteremia*
;
Staphylococcus aureus*
;
Staphylococcus*
7.Food borne illness-Salmonellosis, Virbriosis, Listeriosis.
Korean Journal of Medicine 1998;55(4):701-705
No abstract available.
Listeriosis*
8.The clinical features of hepatosplenic candidiasis.
Kyong Ran PECK ; Myoung Don OH ; Byung Kook KIM ; Kang Won CHOE
Korean Journal of Infectious Diseases 1992;24(4):293-302
No abstract available.
Candidiasis*
9.Malignancies in HIV-infected patients.
Korean Journal of Medicine 2009;76(5):551-553
Human immunodeficiency virus (HIV) infection can produce profound defects in cell-mediated immunity, and HIV-infected patients have a markedly increased incidence of malignancies. Kaposi's sarcoma was the first malignancy to be recognized as a cancer defining acquired immunodeficiency syndrome (AIDS). Non-Hodgkin's lymphoma is also associated with AIDS. HIV-infected patients are also at increased risk of developing cancers related to human papilloma virus, such as cervical cancer and anal cancer. As the life expectancy of HIV-infected patients has increased dramatically with advances in anti-retroviral therapy, the screening and prevention of malignancies should be included in the management of HIV-infected individuals.
Acquired Immunodeficiency Syndrome
;
Anus Neoplasms
;
HIV
;
Humans
;
Immunity, Cellular
;
Incidence
;
Life Expectancy
;
Lymphoma, Non-Hodgkin
;
Mass Screening
;
Papilloma
;
Sarcoma, Kaposi
;
Uterine Cervical Neoplasms
;
Viruses
10.HIV drug resistance in treatment-naive HIV patients.
Korean Journal of Medicine 2007;73(3):235-236
Antiretroviral therapy for treatment of human immunodeficiency virus type 1 (HIV-1) infection has improved steadily since the introduction of combination therapy in 1996. With the advancement of antiretroviral therapy, the mortality of AIDS patients has markedly improved. However, drug resistance has been emerging as a major problem in HIV treatment. Several studies reported that the prevalence of transmitted resistant virus involving antiretroviral-naive people in developed countries was around 10%. Primary drug resistance is rare in HIV-1 infected patients in Korea. A cohort study is need to monitor resistant HIV-1 among newly infected individuals.
Cohort Studies
;
Developed Countries
;
Drug Resistance*
;
HIV*
;
HIV-1
;
Humans
;
Korea
;
Mortality
;
Prevalence